<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39401365</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><Issue>43</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Abortive infection of bat fibroblasts with SARS-CoV-2.</ArticleTitle><Pagination><StartPage>e2406773121</StartPage><MedlinePgn>e2406773121</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2406773121</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2406773121</ELocationID><Abstract><AbstractText>Bats are tolerant to highly pathogenic viruses such as Marburg, Ebola, and Nipah, suggesting the presence of a unique immune tolerance toward viral infection. Here, we compared severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of human and bat (<i>Rhinolophus ferrumequinum</i>) pluripotent cells and fibroblasts. Since bat cells do not express an angiotensin-converting enzyme 2 (ACE2) receptor that allows virus infection, we transduced the human ACE2 (hA) receptor into the cells and found that transduced cells can be infected with SARS-CoV-2. Compared to human embryonic stem cells-hA, infected bat induced Pluripotent Stem Cells (iPSCs)-hA produced about a 100-fold lower level of infectious virus and displayed lower toxicity. In contrast, bat embryonic fibroblast-hA produced no infectious virus while being infectable and synthesizing viral RNA and proteins, suggesting abortive infection. Indeed, electron microscopy failed to detect virus-like particles in infected bat fibroblasts in contrast to bat iPSCs or human cells, consistent with the latter producing infectious viruses. This suggests that bat somatic but not pluripotent cells have an effective mechanism to control virus replication. Consistent with previous results by others, we find that bat cells have a constitutively activated innate immune system, which might limit SARS-CoV-2 infection compared to human cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bisht</LastName><ForeName>Punam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallagher</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0002-2109-1293</Identifier><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrasa</LastName><ForeName>M Inmaculada</ForeName><Initials>MI</Initials><Identifier Source="ORCID">0000-0003-3393-4814</Identifier><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boucau</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6731-7238</Identifier><AffiliationInfo><Affiliation>Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard, Cambridge, MA 02139.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harding</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Déjosez</LastName><ForeName>Marion</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental, and Regenerative Biology, and Black Family Stem CellInstitute, Icahn School of Medicine at Mount Sinai, New York, NY 10502.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godoy-Parejo</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental, and Regenerative Biology, and Black Family Stem CellInstitute, Icahn School of Medicine at Mount Sinai, New York, NY 10502.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisher</LastName><ForeName>Margaret E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Nola</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lytton-Jean</LastName><ForeName>Abigail K R</ForeName><Initials>AKR</Initials><AffiliationInfo><Affiliation>David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gehrke</LastName><ForeName>Lee</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9387-8212</Identifier><AffiliationInfo><Affiliation>Institute for Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zwaka</LastName><ForeName>Thomas P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental, and Regenerative Biology, and Black Family Stem CellInstitute, Icahn School of Medicine at Mount Sinai, New York, NY 10502.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaenisch</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5R01MH104610-24</GrantID><Agency>HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)</Agency><Country /></Grant><Grant><GrantID>Gift</GrantID><Agency>Living Stones Foundation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002685" MajorTopicYN="Y">Chiroptera</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="Y">Fibroblasts</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="Y">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">abortive infection</Keyword><Keyword MajorTopicYN="N">bat cells</Keyword><Keyword MajorTopicYN="N">innate immune system</Keyword></KeywordList><CoiStatement>Competing interests statement:The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>15</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39401365</ArticleId><ArticleId IdType="doi">10.1073/pnas.2406773121</ArticleId><ArticleId IdType="pmc">PMC11513954</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Calisher C. H., et al. , Bats: Important reservoir hosts of emerging viruses. Clin. Microbiol. Rev. 9, 531–545 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1539106</ArticleId><ArticleId IdType="pubmed">16847084</ArticleId></ArticleIdList></Reference><Reference><Citation>Sánchez C. A., et al. , A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia. Nat. Commun. 13, 4380 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363439</ArticleId><ArticleId IdType="pubmed">35945197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hale V. L., et al. , SARS-CoV-2 infection in free-ranging white-tailed deer. Nature 602, 481–486 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8857059</ArticleId><ArticleId IdType="pubmed">34942632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell P. K., et al. , SARS-CoV-2 B.1.1.7 variant infection in Malayan tigers, Virginia, USA. Emerg. Infect. Dis. 27, 3171–3173 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8632162</ArticleId><ArticleId IdType="pubmed">34808082</ArticleId></ArticleIdList></Reference><Reference><Citation>Oreshkova N., et al. , SARS-CoV-2 infection in farmed minks, the Netherlands, April and May. Euro Surveill. 25, 2001005 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403642</ArticleId><ArticleId IdType="pubmed">32553059</ArticleId></ArticleIdList></Reference><Reference><Citation>Irving A. T., Ahn M., Goh G., Anderson D. E., Wang L. F., Lessons from the host defences of bats, a unique viral reservoir. Nature 589, 363–370 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33473223</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke B., et al. , Regulatory T cell-like response to SARS-CoV-2 in Jamaican fruit bats (Artibeus jamaicensis) transduced with human ACE2. PLoS Pathog. 19, e1011728 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10617724</ArticleId><ArticleId IdType="pubmed">37856551</ArticleId></ArticleIdList></Reference><Reference><Citation>Déjosez M., et al. , Bat pluripotent stem cells reveal unusual entanglement between host and viruses. Cell 186, 957–974 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10085545</ArticleId><ArticleId IdType="pubmed">36812912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y. J., et al. , SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182, 429–446 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250779</ArticleId><ArticleId IdType="pubmed">32526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A. C., et al. , Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Y., Shang J., Graham R., Baric R. S., Li F., Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 94, e00127-20 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7081895</ArticleId><ArticleId IdType="pubmed">31996437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D., et al. , Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260–1263 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Estévez-Herrera J., et al. , Zika virus pathogenesis: A battle for immune evasion. Vaccines (Basel) 9, 294 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005041</ArticleId><ArticleId IdType="pubmed">33810028</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese M., et al. , Integrative imaging reveals SARS-CoV-2-induced reshaping of subcellular morphologies. Cell Host Microbe 28, 853–866 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7670925</ArticleId><ArticleId IdType="pubmed">33245857</ArticleId></ArticleIdList></Reference><Reference><Citation>Schountz T., Baker M. L., Butler J., Munster V., Immunological control of viral infections in bats and the emergence of viruses highly pathogenic to humans. Front. Immunol. 8, 1098 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5604070</ArticleId><ArticleId IdType="pubmed">28959255</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarigan R., et al. , Distinct interferon response in bat and other mammalian cell lines infected with Pteropine orthoreovirus. Virus Genes 57, 510–520 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386163</ArticleId><ArticleId IdType="pubmed">34432209</ArticleId></ArticleIdList></Reference><Reference><Citation>Cataldi M., Shah N. R., Felt S. A., Grdzelishvili V. Z., Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1. Virology 485, 340–354 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4619123</ArticleId><ArticleId IdType="pubmed">26331681</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., et al. , Differentially expressed immune response genes in COVID-19 patients based on disease severity. Aging (Albany NY) 13, 9265–9276 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064215</ArticleId><ArticleId IdType="pubmed">33780352</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., et al. , The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct. Target. Ther. 6, 255 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261820</ArticleId><ArticleId IdType="pubmed">34234112</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolotti D., et al. , TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection. Microorganisms 9, 1820 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8465566</ArticleId><ArticleId IdType="pubmed">34576716</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond M. S., Kanneganti T. D., Innate immunity: The first line of defense against SARS-CoV-2. Nat. Immunol. 23, 165–176 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8935980</ArticleId><ArticleId IdType="pubmed">35105981</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke R., Cong M. E., Li D., García-Lerma J. G., Perelson A. S., On the death rate of abortively infected cells: Estimation from simian-human immunodeficiency virus infection. J. Virol. 91, e00352-17 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5571247</ArticleId><ArticleId IdType="pubmed">28679753</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen E. M., Avital N., Shamay M., Kobiler O., Abortive herpes simplex virus infection of nonneuronal cells results in quiescent viral genomes that can reactivate. Proc. Natl. Acad. Sci. U.S.A. 117, 635–640 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6955376</ArticleId><ArticleId IdType="pubmed">31871148</ArticleId></ArticleIdList></Reference><Reference><Citation>Swadling L., et al. , Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature 601, 110–117 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8732273</ArticleId><ArticleId IdType="pubmed">34758478</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M., et al. , SARS-CoV-2 isolates show impaired replication in human immune cells but differential ability to replicate and induce innate immunity in lung epithelial cells. Microbiol. Spectr. 9, e0077421 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8552721</ArticleId><ArticleId IdType="pubmed">34378952</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H., et al. , Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J. Infect. Dis. 213, 904–914 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107330</ArticleId><ArticleId IdType="pubmed">26203058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., et al. , Intrinsic immunity shapes viral resistance of stem cells. Cell 172, 423–438 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5786493</ArticleId><ArticleId IdType="pubmed">29249360</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A., Rapin N., Bollinger T., Misra V., Lack of inflammatory gene expression in bats: A unique role for a transcription repressor. Sci. Rep. 7, 2232 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5440382</ArticleId><ArticleId IdType="pubmed">28533548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn M., et al. , Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host. Nat. Microbiol. 4, 789–799 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7096966</ArticleId><ArticleId IdType="pubmed">30804542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn M., et al. , Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases. Cell 186, 2144–2159 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37172565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., et al. , Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats. Proc. Natl. Acad. Sci. U.S.A. 113, 2696–2701 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4790985</ArticleId><ArticleId IdType="pubmed">26903655</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller O., Kochs G., Human MxA protein: An interferon-induced dynamin-like GTPase with broad antiviral activity. J. Interferon Cytokine Res. 31, 79–87 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21166595</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., et al. , Dampened STING-dependent interferon activation in bats. Cell Host Microbe 23, 297–301 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7104992</ArticleId><ArticleId IdType="pubmed">29478775</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlovich S. S., et al. , The Egyptian Rousette genome reveals unexpected features of bat antiviral immunity. Cell 173, 1098–1110 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112298</ArticleId><ArticleId IdType="pubmed">29706541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins J. A., et al. , A metaanalysis of bat phylogenetics and positive selection based on genomes and transcriptomes from 18 species. Proc. Natl. Acad. Sci. U.S.A. 116, 11351–11360 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6561249</ArticleId><ArticleId IdType="pubmed">31113885</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhosle S. M., et al. , Duplex one-step RT-qPCR assays for simultaneous detection of genomic and subgenomic RNAs of SARS-CoV-2 variants. Viruses 14, 1066 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9143037</ArticleId><ArticleId IdType="pubmed">35632807</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., et al. , Profiling of SARS-CoV-2 subgenomic RNAs in clinical specimens. Microbiol. Spectr. 27, e0018222 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9045320</ArticleId><ArticleId IdType="pubmed">35311586</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A., et al. , STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y., Smyth G. K., Shi W., featureCounts: An efficient general-purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M. I., Huber W., Anders S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., et al. , Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545–15550 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>De Hoon M. J., Imoto S., Nolan J., Miyano S., Open source clustering software. Bioinformatics 20, 1453–1454 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14871861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisht P., Barrasa M. I., Jaenisch R., Abortive infection of bat fibroblasts with SARS-CoV-2. GEO. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274964. Deposited 15 August 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11513954</ArticleId><ArticleId IdType="pubmed">39401365</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>